mechanism of action of glp 1 glp-1_analogs [TUSOM Frontiers | Mechanisms of action
Description
E&OE The author was formerly executive director of Indian Journal of Clinical Practice in an era when there were only JAMA and BMJ as the leading medical journals available for Indian clinicians
Indication bias (patients prescribed GLP-1 agonists may have underlying risk factors for autoimmune disease)
recently published a study on 2562 case subjects that showed an increased risk of all thyroid cancers (adjusted HR 1.58, 95% CI 1.271.95) and medullary thyroid cancer (adjusted HR 1.78, 95% CI 1.043.5) after 13 years of GLP-1 RA use [78]
10.15605/jafes.037.02.14 42
Semaglutide injectionsa breakthrough medication originally developed for type 2 diabetes, now FDA-approved for chronic weight management in adults who are overweight or have obesity, especially those with related health conditions such as high blood pressure, type 2 diabetes, or high cholesterol
